Newburgh Gazette, April 11, 2018. US health officials are placing new restrictions on a contraceptive implant that has been subject to thousands of reports of painful complications from women. NCHR questions if any patients would read the 22 page information booklet to learn about the risks.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
CMS Payment Rule Seen as Bad for Some Patients
MedPage Today, April 10, 2018. New final regulations on the Affordable Care Act health insurance exchanges issued by the Centers for Medicare & Medicaid Services have drawn mixed reactions from health policy experts and others. The changes include expanding the number of “benchmark” plans, adding new “hardship exemptions,” allowing states to adjust the “medical loss ratio,” and increasing the percentage premium increase.
Read More »U.S. FDA Puts Restrictions on Essure Birth Control Implant but No Recall
The Associated Press, April 9, 2018. The Food and Drug Administration announced restrictions on the sale of the Essure contraceptive device. Only women who read and sign a brochure about the risks of the Essure device will be able to receive the implant made by Bayer, but NCHR questions how many patients will read the 22-page booklet.
Read More »FDA Worried Drug Was Risky; Now Reports of Deaths Spark Concern
CNN, April 9, 2018. The FDA approved a Parkinson’s drug that many patients are now being harmed from. NCHR asks: Why are so many patients dying from this new Parkinson’s drug? Should it be taken off the market? Is FDA still the gold standard for protecting patients from harm?
Read More »Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?
Kaiser Health News, April 6, 2018. Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations. Even as these patient groups grow in number and political influence, their funding and their relationships to drugmakers are little understood.
Read More »